Navigation Links
United Therapeutics Corporation to Announce Third Quarter 2010 Financial Results Before Market Open on Thursday, October 28, 2010
Date:10/21/2010

SILVER SPRING, Md., Oct. 21 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will release its third quarter 2010 financial results before market open on Thursday, October 28, 2010.

United Therapeutics will host a half-hour teleconference on Thursday, October 28, 2010, at 9:00 a.m. Eastern Time.  The teleconference is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 1-800-642-1687, with international callers dialing 1-706-645-9291, and using conference code: 14787030.

This teleconference is also being webcast and can be accessed via United Therapeutics' website at http://ir.unither.com/events.cfm.  [uthr-g]

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions.


'/>"/>
SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Sangart, Inc. Receives $1.1 Million Grant Award from the United States Department of Defense for Further Development of MP4 Molecule in Trauma
2. United Therapeutics Corporation to Announce Second Quarter 2010 Financial Results Before Market Open on Wednesday, July 28, 2010
3. Report Details How States Respond to Citizens United Decision
4. United Nations' World Population Day Calls Attention to Key Global Issues
5. United Therapeutics and Lees Pharmaceutical Sign Remodulin Distribution Agreement for China
6. Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States
7. Abt Bio-Pharma Solutions, Inc. Acquired by United BioSource Corporation
8. Scripps Announces Sale of United Medias Licensing Business for $175 Million
9. Peptimmune Announces Second Grant of a United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis
10. United Therapeutics Corporation to Announce Fourth Quarter and Annual 2009 Financial Results Before Market Open on Tuesday, February 16, 2010
11. The Honorable Tommy G. Thompson Joins the United Therapeutics Corporation Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 2015  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... life-threatening diseases, today announced that it will host its ... on Thursday, August 13, 2015 at 4:30 p.m. Eastern ... the release of fiscal 2016 first quarter results.  A ... two hours after the call at the Investor Relations ...
(Date:8/3/2015)... , Aug. 3, 2015 /PRNewswire/ - RepliCel Life Sciences ... company focused on the development of autologous cell therapies, announced ... presenting at the InvestMNT conference held in Minneapolis, ... AM local time. Hall,s presentation will highlight RepliCel,s 18-month milestones ... in Europe , clinical data from both ...
(Date:7/31/2015)... HONG KONG , July 31, 2015 ... "Company"), China,s leading provider of ... and stem cell storage services, today announced that the ... with the U.S. Securities and Exchange Commission. The filed ... year ended March 31, 2015. The Form 20-F can ...
(Date:7/30/2015)... Mass. , July 30, 2015   ... solutions for the interpretation and analysis of genomic ... Matthew Fischer has joined the company as ... Photo - http://photos.prnewswire.com/prnh/20150730/250931 ... capabilities to integrate, interpret, analyze and explore complex ...
Breaking Biology Technology:Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2China Cord Blood Corporation Files Its Annual Report on Form 20-F 2GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2
... Inc., (NYSE: CRY ),a biomaterials, medical device ... first CryoValve(R) SG pulmonary human heart,valve since the ... Administration,(FDA) in February. The procedure was performed on ... Louis, Mo. The CryoValve SG is processed with,the ...
... RepHresh,Vaginal Gel(R) is now available to women in Canada., ... to educate women about their,feminine health, RepHresh Vaginal Gel ... comes to discussing a highly volatile and often,embarrassing subject, ... a successful dialogue between women,doctors, and the media that ...
... for clean water stretches even the resources of the world,s ... technology and novel ideas to find solutions. , Mark Shannon ... of world leaders in water resource research to address this ... issue of Nature. , "As dire as the growing problems ...
Cached Biology Technology:CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve 2CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve 3pH Balanced RepHresh Vaginal Gel(R) now Available to Women in Canada Attacking Tough, Embarrassing Feminine Issues 2pH Balanced RepHresh Vaginal Gel(R) now Available to Women in Canada Attacking Tough, Embarrassing Feminine Issues 3Countering an approaching water crisis 2
(Date:7/13/2015)... Calif. , July 13, 2015 ... developer of human interface solutions, today announced sampling ... touch and display driver integration (TDDI) product targeting ... the first to combine Synaptics , best-in-class ... proven display driver technology developed in the company,s ...
(Date:7/9/2015)... , July 9, 2015  Synaptics ... developer of human interface solutions, today announced ... industry,s first fully hardware encapsulated fingerprint sensor ... authentication technology is literally off the grid, ... biometric matching within the fingerprint sensor to ...
(Date:7/7/2015)... , June 30, 2015 ... has announced the addition of the "Capacitive ... offering. To this date, fingerprint sensing ... technology and fingerprint sensors are well developed. This ... sensing technology. The domain of capacitive ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... battle between the bacterial pathogen Salmonella and the ... at the Biozentrum of the University of Basel has now ... host,s immune system. Their findings are published in the scientific ... is a bacterial infection caused by the pathogen Salmonella ...
... atom located in the vicinity of a molecule can change ... international team of researchers was able to change persistently positions ... by approaching a single copper atom to the molecule. ... simple organic molecule can be switched by approaching a single ...
... or the pipes of an organ, the proteins in the ... Now, a new study provides what researchers say is ... a technique they developed based on terahertz near-field microscopy, scientists ... (HWI) have for the first time observed in detail the ...
Cached Biology News:Typhoid fever -- A race against time 22-proton bit controlled by a single copper atom 22-proton bit controlled by a single copper atom 3The symphony of life, revealed 2The symphony of life, revealed 3
Ideally suited for resolving DNA and RNA 10-1000 bases especially PCR products ranging from 100-1000 bp. Gelling temp. (4%) 27C Melting temperature 65C. EEO: 0.10 Rnase/Dnase: none detected...
XEDAR Antibody...
Xanthine Oxidase (Bovine Buttermilk). Monospecific by IEP. Some cross reactivity with Xanthine Oxidase of other species and tissues may occur....
Rabbit Anti-JNK1/SAPK pan, Polyclonal Antibody...
Biology Products: